Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years
| Autor: | Damon Bass, Regina Kurrasch, Yin Su, Jie Zheng, Yang Li, Guochun Wang, Fengchun Zhang, David A Roth, Jieruo Gu, Jenny Lowe, Myron Chu, Paula Curtis, Kathleen DeRose, Paige Meizlik, Mingjun Wang, Xingfu Li |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | RMD Open, Vol 8, Iss 1 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2056-5933 |
| DOI: | 10.1136/rmdopen-2021-001669 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|